Table 2 Independent associates of diabetes-related lower extremity amputation at baseline in Fremantle Diabetes Study Phase 1 (FDS1) and 2 (FDS2). Odds ratios and 95 % confidence intervals (CI) are shown
| Â | FDS1 | FDS2 | ||
|---|---|---|---|---|
Odds ratio (95Â % CI) | P-value | Odds ratio (95Â % CI) | P-value | |
History or peripheral bypass or revascularisation | 40.15 (8.02–201.09) | <0.001 | 33.50 (6.93–161.86) | <0.001 |
Past hospitalisation for/current foot ulcer |  |  | 91.65 (19.40–433.08) | <0.001 |
Fasting serum glucose (increase of 1 mmol/L) |  |  | 1.36 (1.14–1.62) | 0.001 |
Ln (urinary albumin:creatinine ratio (mg/mmol)) | 2.04 (1.25–3.32) | 0.004 |  |  |
Cerebrovascular disease | 6.11 (1.28–29.16) | 0.023 |  |  |
Peripheral sensory neuropathy | 7.52 (1.16–49.01) | 0.035 |  |  |